SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH)

36 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q1 2022.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21.7M shares of 66.4M outstanding shares and own 32.61% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.32M shares), BANQUE PICTET & CIE SA (2.1M shares), PFM Health Sciences, LP (2.01M shares), CREDIT SUISSE AG/ (1.85M shares), JENNISON ASSOCIATES LLC (1.5M shares), GENERAL ELECTRIC CO (1.11M shares), PRINCIPAL FINANCIAL GROUP INC (877K shares), PURA VIDA INVESTMENTS, LLC (830K shares), and PICTET ASSET MANAGEMENT SA (586K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.